Teva Pharma AG - Methotrexat Teva Onco 500 mg/20 ml, Injektions-/Infusionslösung Swissmedic Registration 47999 Sequence 02 Product name Methotrexat Teva Onco 500 mg/20 ml Description Injektions-/Infusionslösung ATC-Classification L01BA01 ATC-Description Methotrexate Introduction of Sequence 23.10.1987
Composition methotrexatum 500 mg ut methotrexatum natricum, natrii hydroxidum, natrii chloridum, acidum hydrochloridum, aqua ad iniectabile q.s. ad solutionem pro 20 ml corresp. natrium 484.44 mg. Packungsbestandteile Galenic Form Infusion solution Excipiens Active Agent Dose Methotrexate 500mg / 20ml
BAG: Active Agent Dose Methotrexate 500 mg
Inactive agents Acidum Hydrochloridum Sodium Chloride Sodium Hydroxide
Package number Package Size EFP CP Category SL Out of trade (MedRef) 002 52.47 73.50 A SL Yes
